Author(s):
Elwyn Griffiths, DSc, PhD Page: 97-9, 124
Abstract: Regulatory standards for recombinant DNA (rDNA)-derived medicinal products put in place over 40 years ago provided a framework for moving forward with novel biotechnologies and biosimilars leading to their… Read More »
Quality standards for biopharmaceuticals: the importance of good manufacturing practice
Page: 97-9, 124
Abstract: Regulatory standards for recombinant DNA (rDNA)-derived medicinal products put in place over 40 years ago provided a framework for moving forward with novel biotechnologies and biosimilars leading to their… Read More »